Covered recipient · General Payments record
REGINALD A ALLEN
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$2,542.52
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.42 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teleflex LLC | $158.76 | 1 |
| Ferring Pharmaceuticals Inc. | $128.65 | 1 |
| Endo USA, Inc. | $102.78 | 4 |
| PFIZER INC. | $101.21 | 4 |
| Janssen Biotech, Inc. | $53.12 | 3 |
| Endo Pharmaceuticals Inc. | $24.39 | 1 |
| Astellas Pharma US Inc | $21.34 | 1 |
| ABBVIE INC. | $20.02 | 1 |
| Verity Pharmaceuticals Inc. | $14.72 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.02 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208219 | CMS |
| Astellas Pharma US Inc | $21.34 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139330264 | CMS |
| Boston Scientific Corporation | $14.43 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092440330 | CMS |
| Endo Pharmaceuticals Inc. | $24.39 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137012270 | CMS |
| Endo USA, Inc. | $23.19 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138576732 | CMS |
| Endo USA, Inc. | $19.97 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138576734 | CMS |
| Endo USA, Inc. | $29.87 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138576736 | CMS |
| Endo USA, Inc. | $29.75 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138576738 | CMS |
| Ferring Pharmaceuticals Inc. | $128.65 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137460911 | CMS |
| Janssen Biotech, Inc. | $21.15 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078503810 | CMS |
| Janssen Biotech, Inc. | $14.60 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078503785 | CMS |
| Janssen Biotech, Inc. | $17.37 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078504040 | CMS |
| PFIZER INC. | $24.66 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130949426 | CMS |
| PFIZER INC. | $23.94 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131029395 | CMS |
| PFIZER INC. | $25.27 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131885543 | CMS |
| PFIZER INC. | $27.34 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132121204 | CMS |
| Teleflex LLC | $158.76 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142097359 | CMS |
| Verity Pharmaceuticals Inc. | $14.72 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080607657 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.